Dr Lisa Wilde – Director of Research and External Affairs at Bowel Cancer UK

Lisa is a research scientist by training and, since leaving the lab, has spent the last 15 years leading on research management for cancer research charities. Lisa’s expertise lies in research strategy, science communications and science policy. She oversees Communications, Research, and Policy & Campaigns functions.

Mr Kevin Kiely – Medilink

Kevin founded Medilink over 20 years ago, a model which is now licensed to regions across the UK. Kevin is currently the CEO of North of England and International Executive for Medilink UK

 

Kevin leads on Medilink’s innovation service provision across the North of England.   He has 20 years’ experience of facilitating and fast tracking new product developments; successfully converting clinical need and new technology advancements into commercially available solutions.   He is a member of the Royal Society of Medicine, a member of the SBRI Healthcare Board and a technology assessor for a number of funding agencies.

 

As the International Executive for Medilink UK, Kevin facilitates international partnership initiatives and represents government agencies at major events across the world.   He has signed MOUs for cooperation and exchange in trade, technology transfer and R&D with China and Brazil’s largest medical device trade associations.

 

He supports integrated service delivery through partnership working with key national and regional organisations such as NHS England, BEIS, UKRI, DIT/LSO, AHSNs & Local Enterprise Partnerships.

Professor Gordon Cook – Clinical Director – NIHR Leeds In Vitro Diagnostics Co-operative

MB ChB, PhD, FRCP(Glas), FRCPath.
Professor of Haematology & Myeloma Studies, Honorary Consultant Haematologist
Clinical Director (haematology) CTRU
Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds. Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds

I am a graduate of the University of Glasgow School of Medicine & received my higher professional training in haematology in the West of Scotland. After completion of my PhD, I was appointed as a Consultant Haematologist in the West of Scotland before moving to take up the post of Director of Stem Cell Transplantation at Leeds Teaching Hospitals in 2002. In 2013 I was appointed as Professor of Haematology, University of Leeds where I lead the myeloma clinical and translational research portfolio with a primary interest in tumour immunology and immunotherapy.

I am the Chair of the UK Myeloma Research Alliance and NCRI Myeloma sub-group as well as a member of the NCRI Haematology- Oncology Clinical Studies Group. I am the chair of the UK Myeloma Forum and have represented the interests of both myeloma clinicians and patients in NICE reviews. I am Chief Investigator for NCRI Myeloma X (completed), UKMRA Myeloma XII (in recruitment), UKMRA Myeloma XIV (in set-up), MUKeight (in recruitment) and MUKeleven (in recruitment). My collaboration with industry includes my position as the UK Chief investigator for 4 industry international phase III and IIIb studies & I am the chair of the Myeloma UK Research Advisory Group and Medical Editor of Myeloma Today. Finally I hold the posts of Clinical Director of NIHR (Leeds) IVD Cooperative and Clinical Director (Haematology), CTRU, University of Leeds.